If you have primary mediastinal B-cell lymphoma (PMBL), you’ve likely heard about CAR T gene therapy. There’s good reason for that. Loretta Nastoupil, MD, will tell you, “It’s just the most exciting ...
PURPOSE: Primary mediastinal B-cell lymphoma (PMBL) is recognized as a separate disease entity in the REAL classification. There is uncertainty about the relevance and especially the optimal ...
Minimally Invasive Surgery for Early-Stage Cervical Carcinoma: Interpreting the Laparoscopic Approach to Cervical Cancer Trial Results The expansion cohort of the open-label, phase I/II CheckMate 436 ...
Even though it’s one of the latest and greatest cancer treatments, CAR T therapy still has its side effects. They’re often mild, but they can be serious and affect your heart, kidneys, and brain. That ...
Diagnosis of PMBL using clinical and morphological features alone is imprecise, leading to an uncertain prognosis. Both research groups have devised a molecular signature to identify PMBLs and ...
Gene-expression profiling has been used to define 3 molecular subtypes of diffuse large B-cell lymphoma (DLBCL), termed germinal center B-cell-like (GCB) DLBCL ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback